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Purpose: Vestibular schwannomas (VSs) are uncommon benign brain tumors, generally treated
using Gamma Knife radiosurgery (GKRS). However, due to the possible adverse effect of tran-
sient tumor enlargement (TTE), large VS tumors are often surgically removed instead of trea-
ted radiosurgically. Since microsurgery is highly invasive and results in a significant increased
risk of complications, GKRS is generally preferred. Therefore, prediction of TTE for large VS
tumors can improve overall VS treatment and enable physicians to select the most optimal
treatment strategy on an individual basis. Currently, there are no clinical factors known to be
predictive for TTE. In this research, we aim at predicting TTE following GKRS using texture
features extracted from MRI scans.
Methods: We analyzed clinical data of patients with VSs treated at our Gamma Knife center. The
data was collected prospectively and included patient- and treatment-related characteristics and MRI
scans obtained at day of treatment and at follow-up visits, 6, 12, 24 and 36 months after treatment.
The correlations of the patient- and treatment-related characteristics to TTE were investigated using
statistical tests. From the treatment scans, we extracted the following MRI image features: first-order
statistics, Minkowski functionals (MFs), and three-dimensional gray-level co-occurrence matrices
(GLCMs). These features were applied in a machine learning environment for classification of TTE,
using support vector machines.
Results: In a clinical data set, containing 61 patients presenting obvious non-TTE and 38 patients
presenting obvious TTE, we determined that patient- and treatment-related characteristics do not
show any correlation to TTE. Furthermore, first-order statistical MRI features and MFs did not signif-
icantly show prognostic values using support vector machine classification. However, utilizing a set
of 4 GLCM features, we achieved a sensitivity of 0.82 and a specificity of 0.69, showing their prog-
nostic value of TTE. Moreover, these results increased for larger tumor volumes obtaining a sensitiv-
ity of 0.77 and a specificity of 0.89 for tumors larger than 6 cm3.
Conclusions: The results found in this research clearly show that MRI tumor texture provides infor-
mation that can be employed for predicting TTE. This can form a basis for individual VS treatment
selection, further improving overall treatment results. Particularly in patients with large VSs, where
the phenomenon of TTE is most relevant and our predictive model performs best, these findings can
be implemented in a clinical workflow such that for each patient, the most optimal treatment strategy
can be determined. © 2020 The Authors. Medical Physics published by Wiley Periodicals, Inc. on
behalf of American Association of Physicists in Medicine. [https://doi.org/10.1002/mp.14042]
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1. INTRODUCTION
Vestibular schwannomas (VSs) are relatively rare benign brain
tumors, originating from the Schwann cells of the eighth cra-
nial nerve. These tumors make up 8% of the primary brain
tumors diagnosed in the United States1 and have an incidence
of 37.5 per million inhabitants in the Netherlands.2 In the last
few decades, the main treatment goal for VS has shifted from
complete removal of the tumor to functional preservation of
the facial, trigeminal, and cochlear nerves.3 Especially the
introduction of less invasive treatment options and their
reduced risks at post-treatment morbidities has led to this sub-
stantial shift.4 In a systematic review by Wolbers et al., the
authors5 determined that for small- to medium-sized VSs,
radiosurgery is nowadays generally preferred over micro-
surgery. The reason for this preference is the highly invasive
nature of microsurgery, which results in: (a) a higher risk at
mortality, (b) an inferior preservation of the facial nerve func-
tion, (c) a decreased hearing preservation and (d) a lower qual-
ity of life. Moreover, microsurgical treatments invoke a four-
fold larger overall cost on average, compared to radiosurgery.6
However, for large VSs the discussion concerning the best
treatment strategy is still ongoing. Most medical centers con-
sider microsurgical resection as the optimal treatment strat-
egy for these large tumors, as it effectively averts the
compression of surrounding critical brain structures, such as
the brainstem, the cerebellum and the previously mentioned
cranial nerves. Since the risks involved in microsurgery can
be contra-indicative for this strategy, less invasive treatments
such as radiosurgery and radiotherapy have been considered
increasingly in the last decade. These strategies have shown
good results for large VSs and obtained acceptable radiation-
induced morbidities.7–14
Nevertheless, radiosurgical treatments of large VSs remain
controversial due to the possible transient tumor enlargement
(TTE). This radiation-induced swelling of the tumor, also
known as pseudoprogression, occurs in a broad range of
11%–74% of all VS patients in the two to three years following
treatment and can cause a temporary increase in cranial nerve
morbidities.15–30 For large VSs, where the tumor already exhi-
bits a mass effect on the brainstem, this post-radiation effect
may cause severe, and in some cases, life-threatening morbidi-
ties. This adverse effect necessitates salvage treatment, further
increasing the risk of surgical complications.
As TTE is one of the major contra-indicators for radiosur-
gical treatment of large VSs, it would be extremely beneficial
if this effect can be predicted a priori. This will enable physi-
cians to select the most optimal treatment strategy on an indi-
vidual basis. However, it remains unclear why some patients
exhibit TTE, while others do not show TTE but exhibit an
arbitrary volumetric response. Several investigations into the
correlation of tumor- and treatment-related characteristics to
this effect have been reported.15–31 However, their results
remain inconclusive. Treatment-related characteristics, such
as marginal radiation dose and maximum tumor dose, were
found not to correlate with TTE occurrence in all but one
study.27 Some papers describe that tumor volume is
significantly different between VSs presenting TTE and those
that do not,19,27,30 while others could not find this correla-
tion.15–18,24,26,28,29 Also tumor appearance on MRI, classify-
ing a VS tumor as cystic or solid, has been investigated.
Shirato et al. determined that cystic tumors are more likely to
exhibit TTE.31 However, others did not find this correla-
tion17,19,25,28,32 or even observed that cystic tumors are less
likely to exhibit TTE.21
The assumed biological effect of radiosurgery on VS cells
is a combination of acute inflammation and vascular occlu-
sion.33,34 Because of this and the previously described con-
tradicting results, it is hypothesized that differences in tumor
biology may be the cause of TTE in a subset of patients. Ide-
ally, a biopsy is performed to analyze tumor tissue. However,
this is an undesired procedure as post-biopsy hemorrhage is
one the most frequently encountered complications, which
can cause even death due to the VS location close to the
brainstem. The more readily available source of biological
information is through imaging techniques, such as magnetic
resonance imaging (MRI). These scans are already obtained
for diagnostics and may contain information of the biological
tumor features.
We have studied literature to find out as to how far image
analysis techniques were explored for determining features
describing tumor biological properties. In a review by Gillies
et al., the authors reported on the potential power of medical
image analysis using radiomics to facilitate improved clinical
decision making.35 Indeed, numerous studies describe the
ability of employing computer-aided diagnosis using medical
imaging for classifying disease and treatment response. Yang
et al. evaluated tumor-derived MRI-texture features for dis-
criminating molecular subtypes of glioblastomas and the cor-
responding 12-month survival status.36 Their study obtained
area under the receiver operating characteristic (AUC) values
of 0.70 to 0.82 for the specific subtypes, and 0.69 for the 12-
month survival status. Moreover, specifically for radiosurgi-
cal treatment responses, several authors evaluated the possi-
bility to distinguish true tumor growth from radionecrosis in
primary malignant brain tumors and brain metastases. Utiliz-
ing computer-extracted texture features, Tiwari et al. were
able to distinguish cerebral radionecrosis from recurrent brain
tumors on multi-parametric MRI.37 Their method obtained
AUC values of 0.79 on fluid-attenuated inversion recovery
MRI images, both for primary malignant brain tumors and
for brain metastases, thereby outperforming the diagnosis
made by the medical experts. Zhang et al. evaluated 285 tex-
ture features calculated on four different MRI sequences to
find a predictive model distinguishing radionecrosis from
true tumor progression following radiosurgery on brain
metastases.38 They obtained an AUC value of 0.73 using so-
called delta feature values, which represented the change in
feature values from one time-point to the next. Peng et al.
obtained an AUC value of 0.79 on distinguishing radionecro-
sis from tumor progression, using tenfold cross-validation of
their prediction model.39 Wang et al. demonstrated that mul-
ti-modality MRI imaging and radiomics analysis have poten-
tial to identify early treatment response of malignant gliomas
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treated with concurrent radiosurgery and bevacizumab.40
These studies all show the potential of distinguishing differ-
ent radiosurgical treatment responses in malignant brain
tumors. However, the ability to predict such a treatment
response prior to treatment is, in the case of large VS tumors,
crucial as this can lead to a well-informed treatment selection
based on quantitative analysis. Since no clinical- or treat-
ment-related parameters have shown their prognostic values,
it is hypothesized that quantitatively analyzing the tumor
appearance on readily available MRI scans can facilitate pre-
treatment prediction of the TTE effect.
Therefore, the objective of this research is to explore
whether TTE after radiosurgery, specifically Gamma Knife
radiosurgery (GKRS) on VS, can be predicted from the mea-
sured MRI tumor texture characteristics. We analyze several
texture features and apply machine learning as a technique
for classifying the MRI observations. Our results show that
the MRI tumor texture data of VS correlate to TTE, thereby
enabling the prediction of this adverse effect.
2. MATERIALS AND METHODS
In this section, a description of the available data is pre-
sented and the proposed approach is discussed. Figure 1
depicts the flow diagram of the proposed approach, of which
each element is discussed below. The texture feature extrac-
tion methods applied are first-order statistics and second-
order statistics, based on gray-level co-occurrence matrices
(GLCMs) and Minkowski functionals (MFs).
2.A. Data
The data employed in this research consist of prospectively
collected patient- and treatment-related information and clini-
cal MRI image data. The included patients have been selected
based on a volumetric threshold derived from the Koos grade.
This grade is used in a clinical setting to classify the VS
tumor size. This classification is based on the tumor extent,
where Grade I is selected for tumors only present in the audi-
tory canal and Grade IV for tumors displacing the brainstem.
Koos Grade IV is in medical terms considered a large tumor.
For these large tumors, the adverse effects of TTE can cause
severe complications because of the already caused displace-
ment of critical brain structures and cranial nerves. Koos
Grade IV tumors have a corresponding tumor volume of
4.17  2.75 cubic centimeter (cm3).41 In this research, we
therefore selected a lower bound of 1.42 cm3 as the minimum
inclusion threshold. Furthermore, as TTE will occur between
6 and 18 months after treatment, all included patients had at
least an available MRI scan at 6 months following treatment
and were followed-up for at least 18 months. These follow-up
scans were employed for calculating tumor volume changes,
needed for determining whether a TTE has occurred or not.
This resulted in the inclusion of 99 patients.
The obtained patient- and treatment-related information
included age at treatment, tumor volume at treatment [gross
target volume (GTV)], radiation dose to 99% of the GTV,
coverage (ratio between GTV within prescription isodose vol-
ume GTVPIV and GTV), selectivity (ratio between GTVPIV
and PIV), gradient index (ratio between volume enclosed by
half the prescription isodose and PIV), Paddick conformity
index (coverage multiplied by selectivity), number of iso-cen-
ters and the beam-on time. We employed Student’s t-tests to
evaluate differences in these patient- and treatment-related
characteristics between patients that suffered from TTE and
those that did not.
The clinical MRI data employed in this research for tex-
ture analysis consisted of the MRI scans that were already
acquired for treatment planning. These included T1-
weighted, T2-weighted, and contrast-enhanced T1-weighted
(T1CE) MRI scans and were obtained on the day of treat-
ment. Ideally, for discriminating TTE from non-TTE, a
histopathological evaluation of tumor tissue is employed.
However, in current clinical practice, surgical intervention is
highly unwanted due to the significantly increased inherent
risks. This is why the medical team at our center opted for
GKRS in the first place and also has the protocol to only
intervene when the tumor expansion becomes life-threaten-
ing. In all other cases, watchful waiting is preferred for the
first 2–3 yr following GKRS. As such, the presence or
absence of TTE needs to be determined from the MRI data
obtained at follow-up visits. To this end, tumor volumes were
calculated on each available follow-up MRI, by segmenting
the tumor using the treatment planning software (GammaPlan
version 11, Elekta AB, Stockholm, Sweden). These tumor
segmentations were created by authors PL and JV. Several
publications report that the maximum TTE is observed
FIG. 1. Flow diagram of the proposed transient tumor enlargement prediction
approach.
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between 6 to 15 months after treatment, followed by volumet-
ric reduction.16,20,26,28,42 For this reason, the TTE effect is
defined as a volumetric increase of at least 10% within the
first 12 months after treatment, followed by volumetric
reduction to at least the tumor volume at treatment. This
threshold for volumetric increase was chosen based on inter-
and intra-observer variability analysis of the tumor contour-
ing in our center. Examples of the treatment and follow-up
MRI scans of a VS tumor that exhibited TTE are shown in
Fig. 2. If tumor expansion was less than 10% during the first
2 yr, the VS was considered to be stable or shrinking and
consequently classified as non-TTE. Using these definitions
for TTE and non-TTE, 38 out of the included 99 patients
experienced a TTE after GKRS treatment. The remaining 61
patients were classified as non-TTE.
The treatment MRI scans, including the tumor delin-
eations created by the neurosurgeon on the day of treatment,
were extracted from the database of the Gamma Knife treat-
ment system. The data from which image features are
extracted consist of the MRI volume elements (voxels) within
the tumor delineations.
2.B. Pre-processing
Whereas data from other medical imaging modalities are
measured in absolute units, MRI data provides relative val-
ues. To support comparison between subjects, MRI intensi-
ties need to be normalized. To this end, we employ a multi-
landmark intensity normalization (MLIN), which is based on
the work by Madabhushi and Udupa.43 This method aims to
find a generalized intensity scale, such that MRI scanning
parameters have a limited influence on the image analysis
techniques. It performs normalization utilizing tissue-specific
landmarks. For T1 and T1CE MRI scans, the utilized land-
marks are the brainstem and the fiducial markers. For the T2
scans, the selected landmarks are the brainstem, the fiducial
markers, and the cerebrospinal fluid. Examples of the land-
marks are given in Fig. 3.
2.C. Feature extraction
For each tumor, the following first-order statistics (FOS)
are computed from the tumor MRI voxels for each individual
(a) (b) (c)
FIG. 2. T1-weighted, contrast-enhanced magnetic resonance images of a vestibular schwannoma that exhibited transient tumor enlargement after Gamma Knife
radiosurgery. In each part of the figure, the yellow delineation depicts the tumor at time of treatment. Part a: tumor at time of treatment, with a volume of
12.8 cm3. Part b: in green, the tumor 6 months after treatment, with a volume of 17.7 cm3. Part c: in green, the tumor 24 months after treatment, with a volume
of 8.7 cm3.
FIG. 3. Examples of the landmarks used in the multi-landmark intensity normalization method for the T2-weighted magnetic resonance imaging (MRI) scans
(left) and T1-weighted, contrast-enhanced MRI scans (right). For the T1-weighted MRI scans, the same landmarks are used as shown in the right image. High-
lighted in these images are the areas for the cerebrospinal fluid (yellow), brainstem (green) and the fiducial markers (red arrows).
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MRI sequence: mean, standard deviation, skewness, kurtosis
and a 16-bin histogram.
Next, we calculate the MFs as defined by Hadwiger,44
again for each individual MRI sequence. In mathematical
morphology, these functionals represent geometric measure-
ments of shapes. These shapes are obtained by transform-
ing gray-scale images to binary images using a threshold
value. Varying this threshold value will result in multiple
instances from which MFs can be computed. These varia-
tions allow for extracting texture information. From the
binarized data, thresholded at level T, the following elemen-
tary geometric shape objects are extracted: (a) number of
cubes Nc, (b) number of open faces Nf, (c) number of open
edges Ne, and (d) number of open vertices Nv.
45 These
objects are employed in the calculation of the following 4
functionals: foreground volume MT0 , surface area M
T
1 , cur-
vature MT2 , and Euler number M
T
3 . These functionals are
specified by
MT0 ¼ Nc; (1)
MT1 ¼ 6Nc þ 2Nf ; (2)
MT2 ¼ 3Nc  2Nf þ Ne; (3)
MT3 ¼ Nc þ Nf  Ne þ Nv: (4)
The MFs are highly scale-dependent. Since the VS
tumors in our data set have a ratio between minimum and
maximum volume of 13:1, the MFs need to be normalized
with respect to the tumor volume. This is performed by
dividing the functionals by the maximum tumor volume in
the data set.
Finally, for each individual MRI sequence, the GLCMs
are computed. For the GLCM Ph,d,l, each matrix element
Ph,d,l(i,j) denotes the number of times a pixel with inten-
sity i occurs together with a pixel of intensity j, at angle
h, distance d, and quantization level l. Each element is
normalized with respect to the total number of elements
in the GLCM. From these matrices, the following 4 fea-
tures are calculated: entropy (H), contrast (Cn), energy
(E), and correlation (Co).46 These features are specified
by:
H ¼
X
i;j
Ph;d;l i; jð Þ log Ph;d;l i; jð Þ
 
; (5)
Cn ¼
X
i;j
i jj j2Ph;d;l i; jð Þ; (6)
E ¼
X
i;j
P2h;d;l i; jð Þ; (7)
Co ¼
X
i;j
i lið Þ j lj
 
Ph;d;l i; jð Þ
rirj
: (8)
here, i and j are the row and column indices of each GLCM
element, respectively. Parameters µi and ri denote the mean
and standard deviation of row i and µj and rj the mean and
standard deviation of column j, respectively.
2.D. Classiﬁcation
The final step is to train a classifier for binary prediction
of TTE. The implemented machine learning method in this
research is support vector machines (SVM), since it has pro-
ven to be effective in binary classification problems without
requiring large amounts of data. As our data set is relatively
small, containing only 99 tumors, advanced algorithms such
as neural networks are not well-suited for classification. Con-
sidered SVM types include linear, quadratic, cubic, fine
Gaussian, medium Gaussian, and coarse Gaussian, which are
implemented in MATLAB (MathWorks, Natick, Mas-
sachusetts, USA). Validation is performed by tenfold cross-
validation. The performance metrics for determining the opti-
mal model are the sensitivity and specificity of the trained
model. Additionally, models are evaluated by the area under
the curve (AUC) of the receiver operating characteristic
(ROC). The best models are selected based on their sensitiv-
ity and specificity. In case the multiple models perform
equally well, preference is given to a higher specificity: false
positives can be related to miss-predicted occurrence of TTE,
necessitating salvage treatment in a patient. Alternatively,
false negatives are related to a miss-predicted absence of
TTE, resulting in the selection for microsurgical treatment.
Because the first situation has a larger impact on the well-be-
ing of the patient, larger emphasis is placed on specificity.
Training of the models is based on different data inclusion
criteria. The first criterion is derived from the small imbal-
ance in the available data, where the majority class contains
61 patients (non-TTE) and the minority class 38 patients
(TTE). Due to this imbalance, training can lead to a model
that is skewed towards the majority class. This way a classifi-
cation algorithm can obtain a reasonable accuracy, at the cost
of a low specificity. To evaluate whether this imbalance
impacts the results, training is performed in two different
ways. First, all available data points are employed in training
the SVM models. Second, a balanced training set is used, in
which each cohort is equally sized. Balancing the data is per-
formed by random subsampling of the majority class. To
account for possible data biases, a further validation loop is
employed. In this loop, models are trained using n resampled
subsets of the majority class. The resulting model is the aver-
age of these n models, indicating the combined model perfor-
mance.
The second data inclusion criterion is based on the MRI
sequence. In this research, we have T1-, T1CE- and T2-
weighted MRI data available. In the classification approach,
we have evaluated each individual MRI sequence as well as
the combination of all three sequences.
The third data inclusion criterion is based on the tumor
volume. The data from which the MRI image features are
extracted consist of the MRI voxels within the tumor delin-
eations. Due to the employed scanning method and parame-
ters, each tumor is scanned using the same voxel dimensions.
Thus, MRI scans of large tumors contain more tumor voxels
than scans of small tumors. If the number of tumor voxels
increases, the amount of texture information also expands.
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Therefore, we also explored the impact of the tumor volume,
by imposing various volume thresholds for specific selection
of the data (volume filtering). The selected volume thresholds
were 2, 3, 4, 5, 6, and 7 cm3, as higher thresholds resulted in
too few number of patients in the minority class.
3. RESULTS
In this section we first describe the statistical analyses of
the patient- and treatment-related characteristics. Next, the
feature extraction parameters and results are presented.
Finally, the classifier performances with regards to the bal-
ancing of the training data, the employed features and the
tumor volume filtering are given.
3.A. Statistical analysis
For the statistical analysis, all patient- and treatment-re-
lated characteristics of the included patients were obtained
from a prospectively collected database. A summary of the
resulting characteristics can be found in Table I.
First, Student t-tests are employed for evaluating differ-
ences in patient- and treatment-related characteristics
between patients suffering from TTE and those that do not
show TTE. These tests are also performed after implementing
the additional volume thresholds. The resulting p-values are
presented in Table II. None of the tests obtained statistical
significance (P < 0.05), showing that the patient- and treat-
ment-related characteristics have no prognostic value of the
occurrence of TTE. This is fully in agreement with the found
literature on this subject.
3.B. Classiﬁcation performance
This section presents the implemented feature parameters
and results obtained per feature extraction method. For each
extractor, we evaluate the impact of the volume thresholding,
as discussed above. First, the FOS results are discussed. Next,
the results of the MFs are presented and finally, the GLCM-
based results are given.
3.B.1. FOS
The calculated first-order-statistics of the MRI scans are
the mean, standard deviation, skewness and kurtosis. Further-
more, a 16-bin histogram is included, resulting in a total of
20 features per MR image sequence. In Table III, the perfor-
mances for both training strategies, including all available
data and including balanced data, of the best FOS-based
models are presented for the various volume thresholds.
For the FOS-based features, the model based on balanced
training data achieved a sensitivity and specificity of 0.72 and
0.40, respectively. Excluding tumors smaller than 7 cm3 from
the training data improves this performance slightly to values
of 0.66 and 0.58, respectively. Training the SVM models on
all available data resulted in models that were skewed towards
the majority class. This is clearly visible in Table III, where
the values for the specificity are all significantly below 0.50
in all but one of the best-performing models. The model of
TABLE I. Patient- and treatment-related characteristics for the complete
patient cohort.
Mean
Interquartile
range Range
Age (yr) 58 47–66 24–84
Tumor volume at treatment (cm3) 6.54 3.10–6.04 1.44–18.72
Dose to 99% of the tumor
volume (Gy)
12.36 11.80–13.00 11.10–13.20
Coverage (%) 95.74 91.00–99.00 86.00–100.00
Selectivity 0.89 0.85–0.90 0.71–0.99
Gradient index 2.74 2.58–2.82 2.45–3.60
Paddick conformity index 0.84 0.84–0.89 0.17–0.93
Number of iso-centers 24 17–31 1–53
Beam-on time (min) 60.27 42.18–75.03 22.80–144.80
TABLE II. Resulting P-values of the student's t-tests per volume threshold. In
the second row, the number of patients after each volume threshold is given.
None of the P-values reach statistical significance.
Volume
threshold – 2 cm3 3 cm3 4 cm3 5 cm3 6 cm3 7 cm3
Number of
patients (TTE
— non-TTE)
38–
61
34–
58
31–45 25–41 24–
37
19–32 17–26
Age 0.315 0.514 0.696 0.604 0.614 0.643 0.149
Tumor volume
at treatment
0.527 0.513 0.142 0.332 0.191 0.254 0.121
Dose to 99% of
the tumor
volume
0.152 0.145 0.094 0.126 0.204 0.202 0.301
Coverage 0.581 0.739 0.590 0.681 0.672 0.993 0.782
Selectivity 0.909 0.908 0.919 0.980 0.761 0.910 0.739
Gradient index 0.383 0.443 0.248 0.280 0.225 0.378 0.595
Paddick
conformity
index
0.961 0.989 0.954 0.932 0.774 0.740 0.757
Number of iso-
centers
0.792 0.645 0.786 0.499 0.687 0.768 0.819
Beam-on time 0.548 0.630 0.550 0.853 0.504 0.611 0.990
TABLE III. Highest-performing first-order statistics-based models for various
volume thresholds and data selection methods. Training data is either a bal-
anced subset (Balanced) or the entire set (Full).
Volume threshold
Balanced Full
Sensitivity Specificity Sensitivity Specificity
– 0.72 0.44 0.84 0.34
2 cm3 0.48 0.63 0.87 0.29
3 cm3 0.47 0.70 0.73 0.52
4 cm3 0.63 0.50 0.83 0.40
5 cm3 0.46 0.65 0.95 0.25
6 cm3 0.67 0.55 0.94 0.32
7 cm3 0.66 0.58 1.00 0.35
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exception obtained sensitivity and specificity values of 0.73
and 0.52, respectively. It becomes clear that, when including
the results after balancing the training data, FOS-based fea-
tures are not well-suited for predicting TTE.
3.B.2. MFs
The MFs are computed as a function of the binarization
threshold T. These computations can be performed for all
available discrete levels, though the functionals show high
correlation between subsequent thresholds when the differ-
ence between thresholds is small. Therefore, we employ 9
threshold levels equally spaced between 0 and 1. The result-
ing 36 MF features are computed per MRI sequence. For
training the SVM models, we employed each functional MTi
for i = 0,. . .,3 individually, as well as combined. The perfor-
mance metrics of the best MF-based models are given in
Table IV. The performance of the best model employing MF
features, combined with a balanced training set, results in
sensitivity and specificity values of 0.69 and 0.53, respec-
tively. Implementation of the volumetric threshold slightly
increases these metrics to 0.64 and 0.61, respectively, for
7 cm3. The impact of the imbalance in the dataset is less pre-
sent for the MF-trained models, compared to the FOS-trained
models, although some models still are skewed towards the
majority class. The highest-performing MF-based model
trained on all available data obtained sensitivity and speci-
ficity values of 0.80 and 0.60, respectively. These values were
obtained with a minimum volumetric inclusion criterion of
4 cm3.
3.B.3. GLCM
Generally, GLCM matrices are evaluated for the four
unique two-dimensional (2D) directions, chosen as
h 2 0; 45; 90; 135f g. Specific subsets may be chosen
based on existing clinical knowledge. However, such clinical
information is unavailable, due to the unknown factors that
influence TTE. As 3D MRI scans are available, we employ
the 3D extension of the GLCM directions. Each direction is
separated by a 45° rotational offset on the cardinal planes,
resulting in 13 unique GLCM directions per MRI scan. The
second parameter of the GLCM, distance d, is evaluated for
the integer values 1,2,. . .,6. The upper bound of 6 has been
selected according to half the size of the smallest tumor
dimension in the data set. The third parameter, the maximum
number of quantization levels l, affects the fine details
retained in the input image. This parameter is evaluated for
values with power of 2: 22,23,. . .,26. Implementing all param-
eter combinations gives a total of 390 unique GLCMs per
MRI sequence.
The GLCM features employed in training a single SVM
model, are composed of the entropy, contrast, energy and cor-
relation, calculated from a single GLCM. Given the number
of GLCMs per MRI sequence and the number of SVM types,
a total of 9360 GLCM-based models are trained. Table V
shows the results of the top-performing model for each data
inclusion setting.
Initial tests with GLCM-based features were performed
with a balanced training set. Without volumetric exclusion of
data, sensitivity and specificity values of 0.69 and 0.75 are
obtained, respectively. Applying volumetric thresholds on the
data improves model performance. A sensitivity and speci-
ficity of 0.79 and 0.75 are obtained, respectively, when imple-
menting the maximum volume threshold.
Next, the effect of data balancing is explored. Utilizing the
full data set, in contrast to a balanced subset, increases the
number of included samples by more than 20%. The effect of
these additional data yields a performance improvement,
increasing sensitivity and specificity to 0.82 and 0.69, respec-
tively. For a minimum volume inclusion criterion of 6 cm3,
the highest sensitivity and specificity values of 0.77 and 0.89
are obtained, respectively. From these results, it can be con-
cluded that GLCM features contain the most predictive infor-
mation of TTE. Application of all training data compared to a
balanced training set only slightly improves the performance
of these GLCM-based models.
However, the largest effect on the performance for these
models is imposing more strict volumetric data thresholds.
Table V shows this effect on the highest obtained sensitivity
and specificity. A different metric employed to evaluate
model performance is the area under the curve (AUC) of the
TABLE IV. Highest-performing Minkowski functionals-based models for vari-
ous volume thresholds and data selection methods. Training data is either a
balanced subset (Balanced) or the entire set (Full).
Volume threshold
Balanced Full
Sensitivity Specificity Sensitivity Specificity
– 0.69 0.53 0.82 0.50
2 cm3 0.74 0.50 0.80 0.50
3 cm3 0.63 0.59 0.93 0.42
4 cm3 0.61 0.60 0.80 0.60
5 cm3 0.63 0.56 0.73 0.63
6 cm3 0.60 0.67 0.87 0.47
7 cm3 0.65 0.65 0.69 0.64
TABLE V. Highest-performing gray-level co-occurrence matrices-based mod-
els for various volume thresholds and data selection methods. Training data
is either a balanced subset (Balanced) or the entire set (Full).
Volume threshold
Balanced Full
Sensitivity Specificity Sensitivity Specificity
– 0.69 0.75 0.82 0.69
2 cm3 0.64 0.76 0.76 0.65
3 cm3 0.68 0.73 0.84 0.61
4 cm3 0.70 0.75 0.88 0.64
5 cm3 0.67 0.75 0.89 0.67
6 cm3 0.71 0.79 0.77 0.89
7 cm3 0.79 0.75 0.85 0.75
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receiver operating characteristic (ROC). In Fig. 4, the ROC
curves of the best GLCM-based models for the various vol-
ume thresholds are depicted. Here, all thresholds obtain simi-
lar performance. The models obtain AUC values of
approximately 0.90–0.95. These results are validated by per-
forming bootstrapping, resulting in confidence intervals of
approximately 0.80 up to 0.99.
Furthermore, the models obtaining these results show
large variations in their parameters. Among the seven best
models, one for each volume threshold, all three image
modalities perform best at least once. Additionally, all quanti-
zation levels show the same effect, where each level is imple-
mented at least once in the highest-performing models. As
the data mainly differ in volume between these models, the
large variations between parameters indicate the presence of
information on various levels. A combination of models and
features may prove to further enhance the results.
4. DISCUSSION
This research was performed in order to find predictive
features of TTE after GKRS treatment of VS. Previous studies
investigated this problem from a clinical point-of-view.15–31
These studies did not find decisive correlations. Moreover,
several studies contradict the results previously found in other
studies. Therefore, it remains unknown if prediction of TTE is
possible. We were able to achieve a classification sensitivity
and specificity of 0.82 and 0.69, respectively. When employ-
ing volume thresholding, we obtained improved performances
for increasing volumes. For tumors larger than 6 cm3, a sensi-
tivity and specificity of 0.77 and 0.89 were realized, respec-
tively. These results were obtained by employing features
from individual GLCMs and represent the highest-scoring
models. Additionally, multiple models based on individual
GLCMs achieved promising classification results. Combining
features from these individual GLCMs may improve the
presented results and enable prediction of TTE with even
higher accuracy, sensitivity, and specificity. Furthermore, we
determined that features calculated from different MR
sequences also show promising results. Thus, next to combin-
ing features from individual GLCMs, combining features
from different MR sequences can improve these results also.
The three feature extractors implemented in this study
were selected both on technical and on clinical aspects. Tech-
nically speaking, the implemented features and classification
method have a proven track record in other healthcare image
analysis applications, for instance for oncology. Both GLCM
and MFs attempt to measure local changes in gray-level tex-
ture within the MR image, thereby addressing heterogeneous
properties of the tissue. Furthermore, SVM has shown to be
effective in binary classification problems without requiring
large amounts of data. We are aware that these techniques are
at present outperformed by machine learning using convolu-
tional neural networks (CNNs). However, since this work is
the first to explore this data and research question, the dataset
was inherently limited at the beginning, which prevented
straightforward application of this new machine learning
technology. In this view, the current work can serve as a good
baseline benchmark. Furthermore, we consider that starting
with such an advanced technique, clinical application would
only be accepted if the learning network would provide what
is actually learned from the data. Since our exploration has
indicated important features to be used as a reference, we
have learned what is important in the images and this knowl-
edge can be further exploited in developing so-called explain-
able artificial intelligence.
Coming back on the employed feature extractors, but now
from a clinical point of view, we remark that they are based
on the supposition of the neurosurgeons that perform the
GKRS treatment of VS tumors in our center. They surmise
that enhancing tumors with inhomogeneous texture proper-
ties show different behavior than the homogeneously enhanc-
ing tumors. More specifically, inhomogeneity in the form of
dark streaks and dark areas within the enhancing lesion are
considered to be the most informative visual properties. Thus,
we selected the three described feature extractors, since these
can adequately quantify such forms of heterogeneity. How-
ever, the results in this study may further improve by investi-
gating other texture features employed in radiomics analysis
of medical images, which is a point of further research.
A significant confounder in this research is its retrospec-
tive character. One of the disadvantages of the retrospectively
analyzed data is that MR image intensities can vary between
subjects, because MR protocols and scanners may have chan-
ged in the course of time. Despite our attempt to minimize
the impact of the inter-subject MR intensity variations by
implementing an advanced normalization method, these vari-
ations may still be present in the prediction approach, albeit
at reduced level.
Another confounder is the applied definition of TTE. As
stated by Marston et al.,42 TTE is difficult to differentiate
from true tumor growth. Ideally, a histopathological examina-
tion of tumor tissue obtained from resection is employed for
FIG. 4. Receiver operating characteristic curves of the best performing model
per volume threshold setting. Model features derived from gray-level co-oc-
currence matrices, based on a balanced training set.
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determining the ground-truth labeling. However, in the case
of a VS, surgical intervention is only warranted if the mass
effect of the tumor causes life-threatening issues. In all other
cases, the transient swelling is accepted and carefully fol-
lowed-up. Thus, only the volumetric data obtained from the
follow-up MRI scans can be used for determining TTE. Nev-
ertheless, this may have caused an incorrect labeling of the
data, creating uncertainty in the final classification results.
Moreover, inter- and intra-observer variations in measur-
ing tumor volumes make determining true volume changes
difficult. During treatment planning, the VS tumor is seg-
mented by the treating neurosurgeon, using a semi-automatic
contouring tool incorporated in the treatment planning soft-
ware. In the course of time, a total of 6 different neurosur-
geons treated VS tumors at our Gamma Knife center.
Furthermore, the follow-up MRI scans were segmented using
the same tool by one neurosurgeon (JV) and one researcher
(PL). An in-house evaluation of the inter- and intra-observer
variations demonstrated that these variations decreased for
increasing tumor volumes. For volumes larger than 1 cm3,
this variation reduced to <10%. This, together with the con-
founding ground-truth labeling, motivates why we only
included patients who presented obvious TTE and obvious
non-TTE. This strict selection was implemented to create two
distinct cohorts. However, this definition may have caused a
selection bias that has influenced the obtained results.
Furthermore, the inter- and intra-observer variations also
influence the amount of voxels included in the feature extrac-
tion algorithms. However, due to the employed method for
tumor segmentation, the variations in contouring are found in
the so-called partial-volume effects of the MRI scans. These
variations are considered to have a limited impact, because
they constitute <10% of the total amount of voxels and
because features are calculated globally. Nevertheless, it
could have influenced the calculated features and the
obtained results.
These confounding factors may have influenced the
obtained results and the robustness of it. Currently, we are
the only Gamma Knife center in the Netherlands treating
this type of brain tumor. As such, we assume that we have
a good cross-section of all VS patients. Thus, the results
found in this study are most likely applicable to other
Gamma Knife centers as well. However, the obtained
results need to be validated, preferably in a joint multi-cen-
ter setting. This would ensure that these confounding fac-
tors are reduced, thereby improving the robustness of the
obtained results. Furthermore, a prospective study could be
designed to cope with the previously described problems.
Nonetheless, the results achieved in this study strongly sug-
gest the possibility of TTE-prediction for individual treat-
ment selection, making an implementation of this in the
clinical workflow conceivable.
5. CONCLUSIONS
At present, small-to-medium sized VSs are generally trea-
ted using GKRS, as the treatment goal for these tumors has
shifted from complete removal with inherent risks for the cra-
nial nerve functions to less invasive techniques such as
GKRS. However, for large VS tumors, microsurgical excision
remains the preferred treatment strategy. Since the risks
involved in microsurgery can be contra-indicative for this
strategy, less invasive treatments such as radiosurgery and
radiotherapy have been considered increasingly in the last
decade obtaining good results with acceptable radiation-in-
duced morbidities. However, it remains a controversial alter-
native to microsurgery, since one of the major contra-
indications for GKRS on large VSs is the adverse effect of
TTE. Therefore, the possibility of predicting TTE would be
extremely beneficial as this would enable the selection of the
most optimal treatment strategy on an individual basis.
It is hypothesized that the origin of this phenomenon can
be found in variations in individual tumor biology. We
explored the idea that the various tumor appearances on MRI
reflect variations in tumor biology. Therefore, we employed
quantitative MRI texture features derived from conventional
MR images in this research.
Using texture features extracted from MRI data, we were
able to obtain classification sensitivity and specificity values
of 0.77 and 0.89, respectively. These results clearly show that
MRI tumor texture can provide information for enabling the
prediction of TTE. This can form a basis for individual VS
treatment selection, further improving overall treatment
results. Particularly for patients with large VSs, where the
phenomenon of TTE is most relevant and for which our pre-
dictive model performs best, these findings can lead to an
implementation in a clinical workflow such that for each
patient the most optimal treatment strategy can be deter-
mined.
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